Advertisement

Ads Placeholder
Loading...

DSM-Firmenich AG

DSFIR.ASEURONEXT
Consumer Defensive
Household & Personal Products
61.42
0.68(1.12%)
U.S. Market opens in 64h 0m

DSM-Firmenich AG Fundamental Analysis

DSM-Firmenich AG (DSFIR.AS) shows moderate financial fundamentals with a PE ratio of -16.38, profit margin of -7.95%, and ROE of -4.68%. The company generates $11.8B in annual revenue with strong year-over-year growth of 20.44%.

Key Strengths

Cash Position11.89%
PEG Ratio-0.16
Current Ratio1.59

Areas of Concern

ROE-4.68%
Operating Margin8.62%
We analyze DSFIR.AS's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 40.9/100 based on profitability, valuation, growth, and balance sheet metrics. The D grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

D
40.9/100

We analyze DSFIR.AS's fundamental strength across five key dimensions:

Efficiency Score

Weak

DSFIR.AS struggles to generate sufficient returns from assets.

ROA > 10%
-3.33%

Valuation Score

Excellent

DSFIR.AS trades at attractive valuation levels.

PE < 25
-16.38
PEG Ratio < 2
-0.16

Growth Score

Moderate

DSFIR.AS shows steady but slowing expansion.

Revenue Growth > 5%
20.44%
EPS Growth > 10%
1.33%

Financial Health Score

Excellent

DSFIR.AS maintains a strong and stable balance sheet.

Debt/Equity < 1
0.29
Current Ratio > 1
1.59

Profitability Score

Weak

DSFIR.AS struggles to sustain strong margins.

ROE > 15%
-468.25%
Net Margin ≥ 15%
-7.95%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is DSFIR.AS Expensive or Cheap?

P/E Ratio

DSFIR.AS trades at -16.38 times earnings. This suggests potential undervaluation.

-16.38

PEG Ratio

When adjusting for growth, DSFIR.AS's PEG of -0.16 indicates potential undervaluation.

-0.16

Price to Book

The market values DSM-Firmenich AG at 0.88 times its book value. This may indicate undervaluation.

0.88

EV/EBITDA

Enterprise value stands at 6.42 times EBITDA. This is generally considered low.

6.42

How Well Does DSFIR.AS Make Money?

Net Profit Margin

For every $100 in sales, DSM-Firmenich AG keeps $-7.95 as profit after all expenses.

-7.95%

Operating Margin

Core operations generate 8.62 in profit for every $100 in revenue, before interest and taxes.

8.62%

ROE

Management delivers $-4.68 in profit for every $100 of shareholder equity.

-4.68%

ROA

DSM-Firmenich AG generates $-3.33 in profit for every $100 in assets, demonstrating efficient asset deployment.

-3.33%

Following the Money - Real Cash Generation

Operating Cash Flow

DSM-Firmenich AG produces operating cash flow of $1.98B, showing steady but balanced cash generation.

$1.98B

Free Cash Flow

DSM-Firmenich AG produces free cash flow of $1.09B, offering steady but limited capital for shareholder returns and expansion.

$1.09B

FCF Per Share

Each share generates $4.35 in free cash annually.

$4.35

FCF Yield

DSFIR.AS converts 7.35% of its market value into free cash.

7.35%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-16.38

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.16

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.88

vs 25 benchmark

P/S Ratio

Price to sales ratio

1.26

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.29

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.59

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.05

vs 25 benchmark

ROA

Return on assets percentage

-0.03

vs 25 benchmark

ROCE

Return on capital employed

0.04

vs 25 benchmark

How DSFIR.AS Stacks Against Its Sector Peers

MetricDSFIR.AS ValueSector AveragePerformance
P/E Ratio-16.3822.37 Better (Cheaper)
ROE-4.68%1250.00% Weak
Net Margin-7.95%-5215.00% (disorted) Weak
Debt/Equity0.291.23 Strong (Low Leverage)
Current Ratio1.592.47 Neutral
ROA-3.33%-193095.00% (disorted) Weak

DSFIR.AS outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews DSM-Firmenich AG's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

6.98%

Industry Style: Defensive, Dividend, Low Volatility

Growing

EPS CAGR

-75.24%

Industry Style: Defensive, Dividend, Low Volatility

Declining

FCF CAGR

-14.18%

Industry Style: Defensive, Dividend, Low Volatility

Declining

Fundamental Analysis FAQ